Improving Follow up Care for People After Minor Stroke

September 27, 2023 updated by: Imperial College Healthcare NHS Trust

A Feasibility Study Investigating an Early, Personalised, Follow-up Programme for People After Minor Stroke

The goal of this feasibility study is to ascertain if this follow-up programme of care can feasibly be implemented within a healthcare system with people after minor stroke.

The main feasibility questions are:

i) To establish recruitment uptake ii) To establish treatment adherence iii) To determine participant retention. Participants will be randomly allocated to the intervention and control group. Those in the intervention group will receive a follow-up telephone call at two weeks after discharge and a second follow-up appointment at six weeks after discharge. Outcome measures will be taken at twelve weeks after discharge.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • London, United Kingdom
        • Recruiting
        • Imperial College Healthcare NHS Trust
        • Contact:
          • Imperial CHN Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult ≥18
  • Clinical or radiological diagnosis of minor stroke from a stroke consultant.
  • Admitted to HASU or seen in rapid assessment/TIA clinic.
  • Pre-admission mRS of 0-3 with no formal package of care prior to stroke.
  • Discharge mRS of 0-3.
  • No onward referral to community therapy team or for package of care.
  • Has capacity to consent.

Exclusion Criteria:

  • Any serious co-morbidities that would impact a person's ability to participate in the follow-up appointments and outcome measurement.
  • Insufficient English to engage in intervention and outcome measures and no family or friends to support with this.
  • Not resident in England.
  • Pregnant women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard care
All participants will receive a brief routine stroke medical follow-up appointment.
Experimental: Personalised, holistic based follow-up appointments underpinned by self determination theory.
Participants will receive two follow-up appointments at two and six weeks after discharge.

Appointment 1 (two weeks after discharge):

  • Address participants knowledge gaps as regards their stroke, medication and secondary prevention.
  • Detailed biopsychosocial review.
  • Understand participant priorities and jointly set goals.
  • Agreeing onward referrals if needed.
  • Written summary sent to GP with copy to participant.

Appointment 2 (six weeks):

  • Review priorities identified in post stroke review checklist.
  • Review goals and plans from first appointment.
  • Address any new or persistent information gaps.
  • Review hidden impairments that may be impacting on return to work, activities of daily living, relationships or general well-being.
  • Agreeing onward referrals and action plan.
  • Written summary and plan sent to GP.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: Baseline
Proportion of participants randomised relative to the total number meeting the inclusion criteria.
Baseline
Treatment completion rate
Time Frame: 6 weeks post randomisation
Proportion of participants who attend both follow-up appointments
6 weeks post randomisation
Retention rate
Time Frame: 12 weeks post randomisation
Proportion of participants that complete the follow-up questionnaires
12 weeks post randomisation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PROMIS10
Time Frame: 2 weeks and 12 weeks
Patient reported outcome measures information system
2 weeks and 12 weeks
Health Care Climate Questionnaire Short Form
Time Frame: Baseline and 12 weeks
Patient reported outcome measure
Baseline and 12 weeks
MOCA
Time Frame: Baseline and 12 weeks
Cognitive assessment
Baseline and 12 weeks
PHQ9
Time Frame: 12 weeks
Mood score
12 weeks
GAD7
Time Frame: 12 weeks
Anxiety score
12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative interviews
Time Frame: 13 weeks
Semi-structured
13 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer Crow, Imperial College Healthcare NHS Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2023

Primary Completion (Estimated)

May 31, 2024

Study Completion (Estimated)

August 31, 2024

Study Registration Dates

First Submitted

May 22, 2023

First Submitted That Met QC Criteria

June 1, 2023

First Posted (Actual)

June 9, 2023

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 27, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke, Acute

Clinical Trials on Personalised, holistic follow-up appointments underpinned by self determination theory

3
Subscribe